Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital. Biotech Health services Manufacturing Investments 07 June 2025 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 142.95M Round investors: SR OneIntermediate Capital GroupSV Health InvestorsAccess BiotechnologySanofi VenturesSchrodersCanaan Partners Company: Draig Therapeutics Industry: BiotechHealth servicesManufacturing
Tropic raised a $105 million Series C led by Forbion and Corteva, joined by IQ Capital, Just Climate, ABN Amro, Invest International, Temasek, Five Seasons Agriculture Biotech Manufacturing Investments 13 March 2026
Dark Blue Therapeutics was acquired for $840 million by Amgen in the USA Biotech Manufacturing Secondary 06 December 2025
Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders. Health services Manufacturing Pharma Investments 07 November 2025